Skip to content

SCHEDULE 13D/AAccepted Jan 14, 4:13 PM ET

Abivax S.A. SCHEDULE 13D/A

Sofinnova Crossover I

Accepted (ET)

4:13 PM

Jan 14, 2026

Filed

Jan 14, 2026

Documents

1

Size

28.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.